NPM1 and sarcoma: Moreover, we found that NPM1 was closely associated with the survival of patients with ES, and high expression of NPM1 in the ES data of GSE17674 and the sarcoma dataset of TCGA often predicted a poor prognosis for patients (p < 0.05, Figures 9C,D).